•     Testimonials      •     Verdicts      •     Bios      •

Contact Us

Baycol
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

What additional medications were you taking at the time?

Was Gemfibrozil (Lopid) taken while taking Baycol?


Has Rhabdomyolysis been diagnosed?


Have any of the following side effects occurred?








Please further describe side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Bayer Settles More Than 2,900 Lawsuits

Jan 26, 2005 | AP German drug maker Bayer AG said Wednesday it has now settled more than 2,900 suits related to its cholesterol-lowering drug Lipobay, or Baycol, paying more than US$1.1 billion in out-of-court deals.

Bayer pulled Lipobay, marketed as Baycol in the United States, in 2001 after it was linked to a rare muscle-wasting syndrome and about 100 patient deaths.

In a regular posting to its Web site, the Leverkusen-based company said it has now settled 2,933 cases and agreed to pay a total of US$1.113 billion without admitting liability. Some 6,359 cases are still pending.

In November the company said it had reached settlements in 2,895 cases and paid some US$1.1 billion in out-of-court deals.